Understanding ALC and Immune System Impact

So, when you see this ALC count on anybody,

whether it's a seemingly healthy individual or someone you know has cancer,

you could see a number, I'm sure there's just a range,

and if you fall, what, below the acceptable range,

you're at risk, and that would be a potential candidate for this biostrike.

Incredibly correct.

In the sense that the range is if you go below 1,000,

so the normal range is between 1,000 to 4,000,

if you go below the 1,000,

the statistical analysis that's been shown now remarkably in about 200 to 300 publications

is that you have a statistical analysis opportunity to actually have a shortened lifespan.

So this lower ALC, or if you drop below 1,000,

the medical term for that is lymphopenia.

So if you were to Google lymphopenia,

remarkably you'd see papers going all the way to 1990s

that if you have lymphopenia for breast cancer,

lymphopenia for pancreas cancer, lymphopenia for lung cancer,

any cancers you want to choose,

your survival rate is significantly and statistically shortened.

And that makes so much sense because

what ALC is actually is your lymphocytes and your T-cells.

And the lymphocytes and T-cells are the only cells

that really matter to prevent infection,

to prevent cancer, to treat the cancer,

to prevent metastasis.

So it is so obvious from my perspective,

it's simple and yet profound,

that we've unlocked a paradigm change where we treat the host,

i.e. the immune system,

rather than the disease.

In fact, the disease of cancer is really the symptom.

The root cause of the disease is the collapse of the immune system.